GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Myrexis Inc (FRA:R9M) » Definitions » Other Current Assets

Myrexis (FRA:R9M) Other Current Assets : €0.02 Mil (As of Jun. 2013)


View and export this data going back to . Start your Free Trial

What is Myrexis Other Current Assets?

Myrexis's other current assets for the quarter that ended in Jun. 2013 was €0.02 Mil.

Myrexis's quarterly other current assets declined from Dec. 2012 (€1.37 Mil) to Mar. 2013 (€0.11 Mil) and declined from Mar. 2013 (€0.11 Mil) to Jun. 2013 (€0.02Mil).

Myrexis's annual other current assets declined from Jun. 2011 (€1.29 Mil) to Jun. 2012 (€0.93 Mil) declined from Jun. 2012 (€0.93 Mil) to Jun. 2013 (€0.02 Mil).


Myrexis Other Current Assets Historical Data

The historical data trend for Myrexis's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myrexis Other Current Assets Chart

Myrexis Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13
Other Current Assets
Get a 7-Day Free Trial 0.17 0.37 1.29 0.93 0.02

Myrexis Quarterly Data
Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.93 1.36 1.37 0.11 0.02

Myrexis Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.


Myrexis Other Current Assets Related Terms

Thank you for viewing the detailed overview of Myrexis's Other Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Myrexis Business Description

Traded in Other Exchanges
N/A
Address
630 Fifth Avenue, Suite 2260, New York, NY, USA, 10020
Myrexis Inc is engaged in evaluating strategic alternatives, such as identifying, evaluating and making financial investments in life sciences assets.

Myrexis Headlines

No Headlines